Cargile N L, McChesney J D
Appl Microbiol. 1974 May;27(5):991-4. doi: 10.1128/am.27.5.991-994.1974.
Microbiological conversion of drugs and natural products, including sterols and steroids, is an important component of the commercial preparation of these agents. We have developed methodology which allows for the production and selection of mutant organisms capable of specific desirable transformations. This methodology is based upon mutation of wild-type strains which are capable of completely degrading certain sterols and selection of the mutants blocked at the desired conversion. This procedure should be equally useful for many if not all drug classes.
药物和天然产物(包括甾醇和类固醇)的微生物转化是这些药物商业制备的重要组成部分。我们已经开发出一种方法,可用于生产和筛选能够进行特定理想转化的突变生物体。该方法基于对能够完全降解某些甾醇的野生型菌株进行诱变,并筛选在所需转化步骤受阻的突变体。该程序即便不是对所有药物类别,也应该对许多药物类别同样有用。